Trade Gilead ^GILD

Gilead Sciences (NASDAQ:GILD) Given Hold Rating at Needham & Company LLC

Gilead Sciences, Inc. (NASDAQ:GILD) Q1 2025 Earnings Call Transcript

Gilead Sciences (NASDAQ:GILD) Given New $135.00 Price Target at Morgan Stanley

Gilead Sciences (GILD) Stock Movement Explained

Gilead (GILD) Gains EMA Nod for Veklury Use in Young Children | GILD Stock News

Gilead Sciences (GILD) Price Target Raised by Morgan Stanley Amid HIV Pipeline Progress | GILD ...

Gilead Sciences (GILD) Faces Target Price Cut Amid Revenue Shortfall | GILD Stock News

Gilead Sciences (GILD) Declares Stable Dividend Amid EPS Guidance Cut

Gilead Sciences (GILD) Surpasses Earnings Expectations Despite Revenue Miss

Q1 2025 Gilead Sciences Inc Earnings Call Transcript

Gilead Sciences (GILD) Posts Mixed Q1 2025 Results Amidst Product Dynamics

Gilead Sciences (GILD) Lowers 2025 EPS Guidance

Gilead Sciences (GILD) Surpasses Earnings Estimates, Falls Short on Revenue

Gilead Sciences (GILD) Reports Lower-than-Expected Q1 Revenue |

Gilead Sciences Swings to 1Q Profit, But Slashes FY25 EPS Guidance | Morningstar

Intel (INTC) Expected to Report No Change in Earnings | GILD Stock News

Gilead Sciences (GILD) Sees Increased Options Activity Ahead of Earnings | GILD Stock News

Gilead Swings To Profit In Q1 As R&D Charges Ease

Stocks on the Move: Merck, Gilead Sciences, P&G, PG&E Corp, Adobe and the URNM

Coppell Advisory Solutions LLC Has $3.22 Million Stake in Gilead Sciences, Inc. (NASDAQ:GILD)

Harvest Investment Services LLC Acquires New Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)

IPG Q1 2025 Earnings Report on 4/24/2025

GLPI Q1 2025 Earnings Report on 4/24/2025

Gilead Sciences (GILD) Earnings Report Preview: Key Insights for Investors

Gilead Sciences (NASDAQ:GILD) Earns Overweight Rating from Analysts at Cantor Fitzgerald

Silverarc Capital Management LLC Buys New Position in Gilead Sciences, Inc. (NASDAQ:GILD)

CSM Advisors LLC Cuts Stock Position in Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Sold by Stifel Financial Corp

Correction to Gilead Sciences Veklury Sales Guidance Headline on Feb. 11 | Morningstar

Gilead (GILD) Upgraded to Overweight Amid Positive Outlook for HIV Franchise Growth | AAPL ...

Is Gilead Sciences (GILD) a Cheap NASDAQ Stock to Buy According to Hedge Funds?

Gilead Sciences (GILD) Upgraded by Cantor Fitzgerald with Positive Outlook | GILD Stock News

10,000 Shares in Gilead Sciences, Inc. (NASDAQ:GILD) Acquired by Silverarc Capital Management LLC

J. Safra Sarasin Holding AG Sells 20,537 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Sold by Van Lanschot Kempen Investment Management N.V.

Shaping the future of inflammatory bowel disease: a global research agenda for better management and public health response

Gilead Sciences to propel healthcare innovation and cell therapy advancement in Abu Dhabi

Gilead Sciences (GILD) Reports Positive Phase 3 Results for Breast Cancer Treatment | GILD ...

Gilead Sciences (GILD) Surprises with Positive ASCENT-04 Results, Analyst Optimistic | GILD ...

Gilead's (GILD) Trodelvy Shows Promise in Breast Cancer Study

Gilead Sciences Sees Positive Results in Phase 3 Study of Aggressive Breast Cancer | Morningstar

Trodelvy® Plus Keytruda® Demonstrates a Statistically Significan

MetLife Investment Management LLC Buys 6,109 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Curi RMB Capital LLC Has $7.81 Million Stock Position in Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences Reports Positive Data From Phase 3 ASCENT-04/KEYNOTE-D19 Study

4,185 Shares in Gilead Sciences, Inc. (NASDAQ:GILD) Acquired by Gabelli Funds LLC

Gilead Sciences, Inc. (NASDAQ:GILD) Position Reduced by Jump Financial LLC

Analysts' Top Healthcare Picks: Evolent Health (EVH), Gilead Sciences (GILD) | Markets Insider

Natixis Decreases Stock Position in Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Purchased by BI Asset Management Fondsmaeglerselskab A S

Capital International Inc. CA Grows Stock Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Sold by Capital World Investors

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Sold by Dimensional Fund Advisors LP

Gilead Sciences Inc. Purchases New Position in Allogene Therapeutics, Inc. (NASDAQ:ALLO)

2,008,338 Shares in Ikena Oncology, Inc. (NASDAQ:IKNA) Purchased by Gilead Sciences Inc.

16,707,477 Shares in Galapagos NV (NASDAQ:GLPG) Bought by Gilead Sciences Inc.

Gilead Sciences Inc. Invests $19.03 Million in Merus (NASDAQ:MRUS)

6,720,803 Shares in Arcellx, Inc. (NASDAQ:ACLX) Bought by Gilead Sciences Inc.

Gilead Sciences Inc. Acquires New Position in Kyverna Therapeutics, Inc. (NASDAQ:KYTX)

231,663 Shares in Agenus Inc. (NASDAQ:AGEN) Acquired by Gilead Sciences Inc.

Gilead Sciences Inc. Acquires Shares of 4,854,443 Tango Therapeutics, Inc. (NASDAQ:TNGX)

2,209,471 Shares in Assembly Biosciences, Inc. (NASDAQ:ASMB) Acquired by Gilead Sciences Inc.

Edgar Lomax Co. VA Cuts Position in Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Purchased by Forum Financial Management LP

Freedom Investment Management Inc. Sells 2,713 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Capital International Ltd. CA Sells 18,042 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Cadence Bank Sells 114,867 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Sold by Capital International Sarl

Capital Research Global Investors Has $5.35 Billion Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)

Natixis Has $24.96 Million Stock Position in Gilead Sciences, Inc. (NASDAQ:GILD)

Norinchukin Bank The Grows Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)

Belmont Capital LLC Has $869,000 Stake in Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Sold by Capital Group Investment Management PTE. LTD.

NewEdge Advisors LLC Increases Stake in Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences, Inc. (NASDAQ:GILD) Stock Holdings Lessened by Insigneo Advisory Services LLC

Gilead Sciences, Inc. (NASDAQ:GILD) Receives Average Recommendation of "Moderate Buy" from Analysts

Arvest Bank Trust Division Lowers Position in Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences Inc. Invests $447.61 Million in Arcus Biosciences, Inc. (NYSE:RCUS)

Gilead Sciences Inc. Invests $461.73 Million in Galapagos NV (NASDAQ:GLPG)

CANADA LIFE ASSURANCE Co Trims Position in Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences Inc. Buys Shares of 1,156,689 Allogene Therapeutics, Inc. (NASDAQ:ALLO)

5,319,148 Shares in Leap Therapeutics, Inc. (NASDAQ:LPTX) Purchased by Gilead Sciences Inc.

Canada Pension Plan Investment Board Raises Stake in Gilead Sciences, Inc. (NASDAQ:GILD)

Marshall Wace LLP Has $112.40 Million Position in Gilead Sciences, Inc. (NASDAQ:GILD)

Insider Selling: Gilead Sciences, Inc. (NASDAQ:GILD) CFO Sells 2,500 Shares of Stock

Zacks Investment Management Reduces Stock Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)

Nurix Announces FDA Clearance of IND Application for GS-6791/NX-0479 - a Novel IRAK4 Degrader ...

United Capital Financial Advisors LLC Decreases Stake in Gilead Sciences, Inc. (NASDAQ:GILD)

Biomedical HIV Prevention Summit in Atlanta Is the Focus To Drive Meaningful Action With Gilead Sciences

Is Gilead Sciences Inc. (NASDAQ:GILD) the Most Undervalued Quality Stock to Buy Now?

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Sold by Dodge & Cox

Guggenheim Capital LLC Sells 34,237 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Belpointe Asset Management LLC Buys 4,433 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Synovus Financial Corp Trims Stake in Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences Inc (GILD) Advances Oncology Care Through Research Scholars Program | GILD ...